These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10731040)

  • 1. Short-acting NMDA receptor antagonist MRZ 2/576 produces prolonged suppression of morphine withdrawal in mice.
    Belozertseva IV; Danysz W; Bespalov AY
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):279-82. PubMed ID: 10731040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the NMDA receptor channel blockers memantine and MRZ 2/579 on morphine withdrawal-facilitated aggression in mice.
    Sukhotina IA; Bespalov AY
    Psychopharmacology (Berl); 2000 May; 149(4):345-50. PubMed ID: 10867961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists.
    Popik P; Mamczarz J; Fraczek M; Widła M; Hesselink M; Danysz W
    Neuropharmacology; 1998 Aug; 37(8):1033-42. PubMed ID: 9833632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of short-acting NMDA receptor antagonist MRZ 2/576 on morphine tolerance development in mice.
    Belozertseva IV; Danysz W; Bespalov AY
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jun; 361(6):573-7. PubMed ID: 10882030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance.
    Danysz W; Kozela E; Parsons CG; Sladek M; Bauer T; Popik P
    Neuropharmacology; 2005 Mar; 48(3):360-71. PubMed ID: 15721168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mrz 2/579, a fast kinetic NMDA channel blocker, reduces the development of morphine tolerance in awake rats.
    Houghton AK; Parsons CG; Headley MP
    Pain; 2001 Apr; 91(3):201-207. PubMed ID: 11275375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists.
    Zhu H; Barr GA
    Psychopharmacology (Berl); 2000 Jun; 150(3):325-36. PubMed ID: 10923761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive and glycine/NMDA receptor antagonists attenuate withdrawal-induced behaviours and increased hippocampal acetylcholine efflux in morphine-dependent rats.
    Bristow LJ; Hogg JE; Hutson PH
    Neuropharmacology; 1997 Feb; 36(2):241-50. PubMed ID: 9144662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive activity of combination of morphine and NMDA receptor antagonists depends on the inter-injection interval.
    Belozertseva IV; Dravolina OA; Neznanova ON; Danysz W; Bespalov AY
    Eur J Pharmacol; 2000 May; 396(2-3):77-83. PubMed ID: 10822059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of the glycine/NMDA receptor antagonist, (+)-HA966, on morphine dependence in neuropathic rats.
    Christensen D; Guilbaud G; Kayser V
    Neuropharmacology; 2000 Jul; 39(9):1589-95. PubMed ID: 10854903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent.
    Zhu H; Barr GA
    Synapse; 2001 Jun; 40(4):282-93. PubMed ID: 11309844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibogaine attenuation of morphine withdrawal in mice: role of glutamate N-methyl-D-aspartate receptors.
    Leal MB; Michelin K; Souza DO; Elisabetsky E
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):781-5. PubMed ID: 12921910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of acute morphine withdrawal in the neonatal rat by the competitive NMDA receptor antagonist LY235959.
    Jones KL; Zhu H; Jenab S; Du T; Inturrisi CE; Barr GA
    Neuropsychopharmacology; 2002 Mar; 26(3):301-10. PubMed ID: 11850145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of morphine dependence and withdrawal by glycine B site antagonists in rats.
    Kotlińska J
    Pharmacol Biochem Behav; 2001 Jan; 68(1):157-61. PubMed ID: 11274720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice.
    Popik P; Kozela E; Danysz W
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):425-32. PubMed ID: 10763858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA antagonists and clonidine block c-fos expression during morphine withdrawal.
    Rasmussen K; Brodsky M; Inturrisi CE
    Synapse; 1995 May; 20(1):68-74. PubMed ID: 7624831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the locus coeruleus and N-methyl-D-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal.
    Rasmussen K
    Neuropsychopharmacology; 1995 Dec; 13(4):295-300. PubMed ID: 8747753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of MRZ 2/576 with felbamate, lamotrigine, oxcarbazepine and topiramate in the mouse maximal electroshock-induced seizure model.
    Luszczki JJ; Danysz W; Czuczwar SJ
    Pharmacology; 2008; 81(3):259-65. PubMed ID: 18253065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel uncompetitive N-methyl-D-aspartate (NMDA)-receptor antagonist MRZ 2/579 suppresses ethanol intake in long-term ethanol-experienced rats and generalizes to ethanol cue in drug discrimination procedure.
    Hölter SM; Danysz W; Spanagel R
    J Pharmacol Exp Ther; 2000 Feb; 292(2):545-52. PubMed ID: 10640291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.